Study: Obesity surgery can help prevent diabetes

August 22, 2012 by MARILYNN MARCHIONE

Doctors are reporting a new benefit from weight-loss surgery — preventing diabetes. Far fewer obese people developed that disease if they had stomach-shrinking operations rather than usual care to try to slim down, a large study in Sweden found.

The results, published in Thursday's New England Journal of Medicine, are provoking fresh debate about when adjustable bands and other bariatric procedures should be offered.

It is "provocative and exciting" that surgery can prevent , but it is "impractical and unjustified" to think of doing it on millions of obese adults, Dr. Danny Jacobs, a Duke University surgeon, wrote in a commentary in the medical journal.

Dr. Mitchell Roslin, bariatric surgery chief at Lenox Hill Hospital in New York, disagreed.

"If surgery is the only treatment we have, we have to accept the cost ramifications of that" and give up "the naive notion" that we can just teach severely obese people how to lose weight, said Roslin, who consults for some makers of bariatric surgery equipment.

Millions of Americans have Type 2 diabetes brought on by obesity. Earlier this year, two studies showed that obesity surgery can reverse diabetes and keep it away for many years, possibly for good.

The new study went a step further, to see if it could prevent diabetes in the first place among people who are obese.

Researchers led by Dr. Lars Sjöström of Sahlgrenska University Hospital in Gothenburg, Sweden, tracked 1,658 patients who had bariatric surgery — mostly bands and stomach stapling — and 1,771 similar patients who just got usual care and counseling on how to lose weight.

None had diabetes when the study began. After about 10 years on average among those still in the study, 392 developed diabetes in the usual care group versus 110 in the surgery group. Researchers calculated that surgery had reduced the odds of getting diabetes by 78 percent.

That is "absolutely remarkable," said Dr. Philip Schauer, a Cleveland Clinic surgeon who also has consulted for some surgery equipment makers and thinks surgery should be used more often for obesity.

costs $15,000 to $25,000. Proponents note that complications of diabetes and obesity are expensive, too, especially if dialysis or a kidney transplant is needed.

The government recently lowered the weight limits for gastric band for those with diabetes or heart disease.

Explore further: Risk of maternal and newborn complications may be lower after bariatric surgery

More information:
Weight-loss info: win.niddk.nih.gov

Body Mass Index calculator: www.nhlbisupport.com/bmi/bminojs.htm

New England Journal: www.nejm.org

shares

Related Stories

Study Puts Bariatric Surgery for Type 2 Diabetes to the Test

December 29, 2009

(PhysOrg.com) -- A multi-disciplinary team of Penn researchers, including diabetes, weight loss and bariatric surgery experts, are conducting a study funded by the National Institutes of Health (NIH) to determine if bariatric ...

Exercise plays key role in managing obesity: study

February 21, 2012

(Medical Xpress) -- In spite of recent media reports suggesting that exercise may not be useful in obesity management, overweight and obese people should not be discouraged from taking it up, according to a paper published ...

Race might play role in success of weight-loss surgery

June 20, 2012

(HealthDay) -- Black women without diabetes lost about 10 percent less weight than white women after having a weight-loss procedure called gastric bypass surgery, but having diabetes helped increase their weight loss, a new ...

Recommended for you

Diets avoiding dry-cooked foods can protect against diabetes

August 24, 2016

Simple changes in how we cook could go a long way towards preventing diabetes, say researchers at the Icahn School of Medicine at Mount Sinai. A new randomized controlled trial, published online July 29 in the journal Diabetologia, ...

New study reveals a novel protein linked to type 2 diabetes

August 16, 2016

Findings from Boston University School of Medicine (BUSM), which appear in eLife, provide a possible explanation as to why most people who are obese develop insulin resistance and type 2 diabetes. A minority of obese individuals, ...

Gene variant explains differences in diabetes drug response

August 9, 2016

The first results from a large international study of patients taking metformin, the world's most commonly used type 2 diabetes drug, reveal genetic differences among patients that may explain why some respond much better ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.